Form 4 for NEPH NEPHROS INC

Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-05 · accession 0001062993-23-000718 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-01-09	2023-01-05	NEPH	Amron Arthur H	Dir	A - Grant	$0.00	+27.6K	27.6K	New	$0
D	2023-01-09	2023-01-05	NEPH	Amron Arthur H	Dir	A - Grant	$0.00	+7,080	7,080	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-01-05	A	A	27,613	$0.00	27,613	D	—	—	(F1) On January 5, 2023, the Company granted 27,613 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Amron in respect of his services as a member of the Board of Directors of the Company for 2022. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Restricted Stock was granted to Wexford Capital LP. The Restricted Stock vests 6 months following the grant date.
2	Derivative	Stock Option (Right to Buy)	2023-01-05	A	A	7,080	$0.00	7,080	D	$1.07 · — to 2033-01-05	7,080 Common Stock	(F2) On January 5, 2023, the Company granted an option to purchase 7,080 shares of common stock of the Company (the "Option") in respect of the service by Mr. Amron as a member of the Board of Directors of the Company for 2022. The Option was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). At the request of Mr. Amron, the Option was granted to Wexford Capital LP. The Option vests as to 2,360 shares on each of 1/5/2023, 1/5/2024 and 1/5/2025.